Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine for arterial stiffness in isolated systolic hypertension
NCT04423627Phase 1Completed
- Sponsor
- University of Iowa
- Start
- Jun 2021
- Primary completion
- Jul 2025
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Clonidine Lauriad in isolated systolic hypertension (ISH) (3 arms), sponsored by University of Iowa. Primary endpoint: Change in carotid-femoral pulse wave velocity at 4 weeks. Started Jun 2021; status: completed.
02
Drugs
Clonidine Lauriad
03
Conditions
isolated systolic hypertension (ISH)
Beyond the preview
Go deeper on NCT04423627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04423627.